BMJ UK BMJ Americas BMJ Brazil BMJ China BMJ India

Temporal link between medicinal cannabis for epilepsy and early puberty

  • BMJ
  • /
  • Newsroom
  • /
  • Newsroom
  • /
  • Temporal link between medicinal cannabis for epilepsy and early puberty

Temporal link between medicinal cannabis for epilepsy and early puberty

Some previously published studies have linked cannabis to increased testosterone levels

The use of medical cannabis for severe childhood epilepsy may be linked to early puberty, doctors have warned in the journal BMJ Case Reports after treating a 2 year old boy with the condition.

Some previously published studies have linked cannabis use to increased levels of the male hormone testosterone, raising the question of a possible dose-related effect as higher strength preparations are readily available, the report authors point out. 

Research suggests that cannabis oil may help cut the risk of seizures in childhood epilepsy. But as yet, there’s no consensus on its impact on a trio of glands, known as the hypothalamo-pituitary-gonadal (HPG) axis. 

This trio is responsible for the development and regulation of several of the body systems, including those for reproduction.

The start of puberty before the age of 9 in boys, formally known as precocious puberty, is attributed to premature activation of the HPG axis. Doctors diagnosed it in a 2-year-old boy who showed signs of puberty including genital enlargement and growth of body hair.

His mother said these changes had started happening 6 months earlier, and a month after she had begun giving him cannabis oil. She had bought this online without prescription to ease his severe epilepsy, which hadn’t responded to any other treatment. 

She explained that her son had had over 20 seizures every day since birth, and that these had become more frequent over time. He also had developmental delay, manifest in poor muscle tone and control, and impaired vision.

The cannabis oil had reduced the number of his daily seizures to 5, she said.

Tests revealed that the boy’s testosterone level was abnormally high as were levels of other reproductive hormones. He was treated with drugs to dampen down the activity and effects of all these hormones.

The report authors note that the research on the effectiveness of cannabis oil for reducing seizure frequency in epilepsy has mostly been done in the laboratory rather than on people.

“More research on the effects of cannabis use on human hormonal markers and clinical outcomes is necessary, and is expected as cannabis continues to become legalised in more countries,” they suggest.

This is just one case report, and no previous cases of early puberty associated with cannabinoid use have been reported, caution the authors.

And while there seems to be a temporal link, “It is unclear whether the precocious puberty seen in our patient is a direct result of activation of the HPG axis by [cannabis],” they emphasise. 

Still, doctors should be aware of the potential hormonal consequences of cannabis use, they write.

“Until a more robust evidence base is established, clinicians should be cautious of hormonal consequences of cannabis-related products, particularly as children with brain abnormalities may be more susceptible to these effects,” they conclude.



Notes for editors
Please note: out of respect for patient confidentiality we don’t have the names or contact details of the cases reported in this journal.

Case Report: Development of central precocious puberty following cannabinoid use for paediatric epilepsy: causal or coincidence? Doi 10.1136/bcr-2020-239678
Journal: BMJ Case Reports

Funding: None declared

Link to Academy of Medical Sciences labelling system

Externally peer reviewed? Yes
Evidence type: Single case report
Subjects: People

BMJ Expert Media Panel

If you are a journalist needing to speak to an expert, please click here.

Browse our Expert Media Panel


Latest coverage of BMJ in the national and international media



If you are a journalist who would like to receive our press releases, please provide your details.



Email the UK media relations team for more information.